A randomised trial of MACC chemotherapy with or without lonidamine in advanced non-small cell lung cancer

This publication has 36 references indexed in Scilit:

• Aspects of quality of life in patients with lung cancer: A three observer evaluation study : Buccheri GF, Vola F, Ferrigno D. Via Repubblica 10-c, I-12018 Roccavlone. Int J Oncol 1993;2:537–44
  Lung Cancer, 1994
• Serum tumour markers in lung cancer: history, biology and clinical applications
  European Respiratory Journal, 1994
• Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancer
  Lung Cancer, 1993
• A phase II study of methotrexate, doxorubicin, cyclophosphamide, and lomustine chemotherapy and lonidamine in advanced non-small cell lung cancer
  Cancer, 1993
• Polychemotherapy in advanced non small cell lung cancer: a meta-analysis
  The Lancet, 1993
• Further evidence in favour of chemotherapy for inoperable non-small cell lung cancer
  Lung Cancer, 1990
• Continuation of chemotherapy versus supportive care alone in patients with inoperable non-small cell lung cancer and stable disease after two or three cycles of MACC. Results of a randomized prospective study
  Cancer, 1989
• MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer
  Cancer, 1979
• Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide
  Journal of Chronic Diseases, 1960
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958